OCD
49
16
20
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 49 trials
100.0%
+13.5% vs benchmark
6%
3 trials in Phase 3/4
50%
5 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (49)
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Open-Label Psilocybin Study in Transdiagnostic Population
A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
Neurostimulation Versus Therapy for Problems With Emotions
Accelerated TMS for Depression and OCD
Objective Characterizatoion of Repetitive Behaviors
Cerebral and Cognitive Markers of Treatment Resistance in Obsessive Compulsive Disorder
Arbitration Between Habitual and Goal-directed Behavior in Obsessive-compulsive Disorder: Circuit Dynamics and Effects of Noninvasive Neurostimulation
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
Paired tVNS With ERP in OCD
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
Neuromodulation for a Novel OCD Biomarker and Treatment
Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
Locating Biomarkers in OCD Through Behavioral Tasks
Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
Light Therapy for Obsessive-compulsive Disorder (OCD)
Testing a Transdiagnostic TMS Treatment Target
Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories
Personalized DBS for OCD Guided by Stereoencephalography Mapping